导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 29.35% | 134/1050 |
| 近一周 | 0.20% | 41/1104 |
| 近一月 | -4.91% | 599/1102 |
| 近一季 | -16.50% | 882/1092 |
| 近半年 | 18.57% | 158/1070 |
| 近一年 | 38.02% | 115/1018 |
| 近两年 | 165.19% | 83/926 |
| 近三年 | 93.78% | 99/834 |
| 成立以来 | 475.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.41% 390/1070 |
84.86% 83/1101 |
- - |
- - |
| 2025 | 36.30% 377/1065 |
5.47% 380/1014 |
-1.44% 809/1038 |
38.75% 214/1050 |
-5.50% 720/1065 |
| 2024 | 11.57% 252/1011 |
-11.72% 821/960 |
0.17% 296/983 |
9.49% 659/991 |
15.22% 31/1011 |
| 2023 | -12.71% 426/952 |
2.58% 473/880 |
-4.11% 460/895 |
-10.13% 594/915 |
-1.25% 181/952 |
| 2022 | -29.29% 607/867 |
-20.26% 529/773 |
11.13% 220/806 |
-17.76% 700/845 |
-2.97% 575/867 |
| 2021 | 45.37% 22/740 |
-7.86% 446/580 |
32.26% 47/659 |
16.14% 29/704 |
2.70% 321/740 |
| 2020 | 59.88% 197/554 |
10.27% 41/419 |
24.05% 209/466 |
6.08% 342/517 |
10.18% 354/554 |
| 2019 | 94.11% 2/410 |
37.01% 106/1146 |
-7.43% 882/1228 |
27.72% 2/390 |
19.83% 15/410 |
| 2018 | -16.23% 36/349 |
- - |
-10.47% 507/990 |
-2.59% 337/1000 |
-6.89% 101/1080 |
| 2017 | 39.27% 16/285 |
- - |
- - |
- - |
- - |
| 2016 | -5.91% 48/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 信澳新能源产业股票 VS. 东吴新产业精选股票A(580008) |